Skip to main content

Table 4 Spearman correlation analysis of AGEs and other indicators

From: Correlation between the accumulation of skin glycosylation end products and the development of type 2 diabetic peripheral neuropathy

Indicators rs P
CVD risk score .831** .000
DPN risk score .756** .000
DR risk score .813** .000
DN risk score .818** .000
TG −.040 .346
HDL-C .039 .366
Cr .395** .000
CysC .381** .000
Hcy .232** .000
ACR .179** .003
eGFR −.434** .000
MAU .248** .000
α-MG .354** .000
Tf .303** .000
Ig .257** .000
NEUT .221** .000
LY −.117** .006
NLR .248** .000
CRP .143** .001
HOMAIR −.313** .006
PFG .037 .398
FINS −.241* .035
C-Peptide −.022 .727
2hC-Peptide −.086 .167
HbA1c .003 .945
TCSS score .454** .000
  1. ** Significant correlation at .01 level; * significantly correlated at the .05 level